The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Influenza Vaccination Market Research Report 2024
Synopsis
Influenza (flu) is a contagious respiratory disease caused by influenza viruses that infect the respiratory tract (nose, throat, and lungs) in humans. The symptoms and complications of flu are more severe than common cold. The symptoms associated with influenza may include fever, headache, malaise, cough, sore throat, nasal congestion, and body aches. Influenza vaccine can prevent illness and death caused
The global Influenza Vaccination market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Stringent regulatory framework along with the low accessibility of the product in the developing countries may restrain the market growth.
This report aims to provide a comprehensive presentation of the global market for Influenza Vaccination, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Influenza Vaccination.
Report Scope
The Influenza Vaccination market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Influenza Vaccination market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Influenza Vaccination companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbott (U.S.)
AstraZeneca (Europe)
BioCryst Pharmaceuticals (U.S.)
Novartis (Europe)
DAIICHI SANKYO COMPANY (Asia Pacific)
GlaxoSmithKline (Europe)
Hualan Biological Engineering (Asia Pacific)
Mitsubishi Tanabe Pharma (Asia Pacific)
F. Hoffmann-La Roche (Europe)
Sanofi (Europe)
Segment by Type
Egg Based
Cell Culture
Recombinant
Segment by Application
Hospitals
Research Organizations
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Influenza Vaccination companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Influenza (flu) is a contagious respiratory disease caused by influenza viruses that infect the respiratory tract (nose, throat, and lungs) in humans. The symptoms and complications of flu are more severe than common cold. The symptoms associated with influenza may include fever, headache, malaise, cough, sore throat, nasal congestion, and body aches. Influenza vaccine can prevent illness and death caused
The global Influenza Vaccination market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Stringent regulatory framework along with the low accessibility of the product in the developing countries may restrain the market growth.
This report aims to provide a comprehensive presentation of the global market for Influenza Vaccination, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Influenza Vaccination.
Report Scope
The Influenza Vaccination market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Influenza Vaccination market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Influenza Vaccination companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbott (U.S.)
AstraZeneca (Europe)
BioCryst Pharmaceuticals (U.S.)
Novartis (Europe)
DAIICHI SANKYO COMPANY (Asia Pacific)
GlaxoSmithKline (Europe)
Hualan Biological Engineering (Asia Pacific)
Mitsubishi Tanabe Pharma (Asia Pacific)
F. Hoffmann-La Roche (Europe)
Sanofi (Europe)
Segment by Type
Egg Based
Cell Culture
Recombinant
Segment by Application
Hospitals
Research Organizations
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Influenza Vaccination companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Influenza Vaccination Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Egg Based
1.2.3 Cell Culture
1.2.4 Recombinant
1.3 Market by Application
1.3.1 Global Influenza Vaccination Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Research Organizations
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Influenza Vaccination Market Perspective (2019-2030)
2.2 Influenza Vaccination Growth Trends by Region
2.2.1 Global Influenza Vaccination Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Influenza Vaccination Historic Market Size by Region (2019-2024)
2.2.3 Influenza Vaccination Forecasted Market Size by Region (2025-2030)
2.3 Influenza Vaccination Market Dynamics
2.3.1 Influenza Vaccination Industry Trends
2.3.2 Influenza Vaccination Market Drivers
2.3.3 Influenza Vaccination Market Challenges
2.3.4 Influenza Vaccination Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Influenza Vaccination Players by Revenue
3.1.1 Global Top Influenza Vaccination Players by Revenue (2019-2024)
3.1.2 Global Influenza Vaccination Revenue Market Share by Players (2019-2024)
3.2 Global Influenza Vaccination Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Influenza Vaccination Revenue
3.4 Global Influenza Vaccination Market Concentration Ratio
3.4.1 Global Influenza Vaccination Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Influenza Vaccination Revenue in 2023
3.5 Influenza Vaccination Key Players Head office and Area Served
3.6 Key Players Influenza Vaccination Product Solution and Service
3.7 Date of Enter into Influenza Vaccination Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Influenza Vaccination Breakdown Data by Type
4.1 Global Influenza Vaccination Historic Market Size by Type (2019-2024)
4.2 Global Influenza Vaccination Forecasted Market Size by Type (2025-2030)
5 Influenza Vaccination Breakdown Data by Application
5.1 Global Influenza Vaccination Historic Market Size by Application (2019-2024)
5.2 Global Influenza Vaccination Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Influenza Vaccination Market Size (2019-2030)
6.2 North America Influenza Vaccination Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Influenza Vaccination Market Size by Country (2019-2024)
6.4 North America Influenza Vaccination Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Influenza Vaccination Market Size (2019-2030)
7.2 Europe Influenza Vaccination Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Influenza Vaccination Market Size by Country (2019-2024)
7.4 Europe Influenza Vaccination Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Influenza Vaccination Market Size (2019-2030)
8.2 Asia-Pacific Influenza Vaccination Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Influenza Vaccination Market Size by Region (2019-2024)
8.4 Asia-Pacific Influenza Vaccination Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Influenza Vaccination Market Size (2019-2030)
9.2 Latin America Influenza Vaccination Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Influenza Vaccination Market Size by Country (2019-2024)
9.4 Latin America Influenza Vaccination Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Influenza Vaccination Market Size (2019-2030)
10.2 Middle East & Africa Influenza Vaccination Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Influenza Vaccination Market Size by Country (2019-2024)
10.4 Middle East & Africa Influenza Vaccination Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbott (U.S.)
11.1.1 Abbott (U.S.) Company Detail
11.1.2 Abbott (U.S.) Business Overview
11.1.3 Abbott (U.S.) Influenza Vaccination Introduction
11.1.4 Abbott (U.S.) Revenue in Influenza Vaccination Business (2019-2024)
11.1.5 Abbott (U.S.) Recent Development
11.2 AstraZeneca (Europe)
11.2.1 AstraZeneca (Europe) Company Detail
11.2.2 AstraZeneca (Europe) Business Overview
11.2.3 AstraZeneca (Europe) Influenza Vaccination Introduction
11.2.4 AstraZeneca (Europe) Revenue in Influenza Vaccination Business (2019-2024)
11.2.5 AstraZeneca (Europe) Recent Development
11.3 BioCryst Pharmaceuticals (U.S.)
11.3.1 BioCryst Pharmaceuticals (U.S.) Company Detail
11.3.2 BioCryst Pharmaceuticals (U.S.) Business Overview
11.3.3 BioCryst Pharmaceuticals (U.S.) Influenza Vaccination Introduction
11.3.4 BioCryst Pharmaceuticals (U.S.) Revenue in Influenza Vaccination Business (2019-2024)
11.3.5 BioCryst Pharmaceuticals (U.S.) Recent Development
11.4 Novartis (Europe)
11.4.1 Novartis (Europe) Company Detail
11.4.2 Novartis (Europe) Business Overview
11.4.3 Novartis (Europe) Influenza Vaccination Introduction
11.4.4 Novartis (Europe) Revenue in Influenza Vaccination Business (2019-2024)
11.4.5 Novartis (Europe) Recent Development
11.5 DAIICHI SANKYO COMPANY (Asia Pacific)
11.5.1 DAIICHI SANKYO COMPANY (Asia Pacific) Company Detail
11.5.2 DAIICHI SANKYO COMPANY (Asia Pacific) Business Overview
11.5.3 DAIICHI SANKYO COMPANY (Asia Pacific) Influenza Vaccination Introduction
11.5.4 DAIICHI SANKYO COMPANY (Asia Pacific) Revenue in Influenza Vaccination Business (2019-2024)
11.5.5 DAIICHI SANKYO COMPANY (Asia Pacific) Recent Development
11.6 GlaxoSmithKline (Europe)
11.6.1 GlaxoSmithKline (Europe) Company Detail
11.6.2 GlaxoSmithKline (Europe) Business Overview
11.6.3 GlaxoSmithKline (Europe) Influenza Vaccination Introduction
11.6.4 GlaxoSmithKline (Europe) Revenue in Influenza Vaccination Business (2019-2024)
11.6.5 GlaxoSmithKline (Europe) Recent Development
11.7 Hualan Biological Engineering (Asia Pacific)
11.7.1 Hualan Biological Engineering (Asia Pacific) Company Detail
11.7.2 Hualan Biological Engineering (Asia Pacific) Business Overview
11.7.3 Hualan Biological Engineering (Asia Pacific) Influenza Vaccination Introduction
11.7.4 Hualan Biological Engineering (Asia Pacific) Revenue in Influenza Vaccination Business (2019-2024)
11.7.5 Hualan Biological Engineering (Asia Pacific) Recent Development
11.8 Mitsubishi Tanabe Pharma (Asia Pacific)
11.8.1 Mitsubishi Tanabe Pharma (Asia Pacific) Company Detail
11.8.2 Mitsubishi Tanabe Pharma (Asia Pacific) Business Overview
11.8.3 Mitsubishi Tanabe Pharma (Asia Pacific) Influenza Vaccination Introduction
11.8.4 Mitsubishi Tanabe Pharma (Asia Pacific) Revenue in Influenza Vaccination Business (2019-2024)
11.8.5 Mitsubishi Tanabe Pharma (Asia Pacific) Recent Development
11.9 F. Hoffmann-La Roche (Europe)
11.9.1 F. Hoffmann-La Roche (Europe) Company Detail
11.9.2 F. Hoffmann-La Roche (Europe) Business Overview
11.9.3 F. Hoffmann-La Roche (Europe) Influenza Vaccination Introduction
11.9.4 F. Hoffmann-La Roche (Europe) Revenue in Influenza Vaccination Business (2019-2024)
11.9.5 F. Hoffmann-La Roche (Europe) Recent Development
11.10 Sanofi (Europe)
11.10.1 Sanofi (Europe) Company Detail
11.10.2 Sanofi (Europe) Business Overview
11.10.3 Sanofi (Europe) Influenza Vaccination Introduction
11.10.4 Sanofi (Europe) Revenue in Influenza Vaccination Business (2019-2024)
11.10.5 Sanofi (Europe) Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
